404 related articles for article (PubMed ID: 21762539)
1. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells.
Chen PM; Yen ML; Liu KJ; Sytwu HK; Yen BL
J Biomed Sci; 2011 Jul; 18(1):49. PubMed ID: 21762539
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.
Melief SM; Zwaginga JJ; Fibbe WE; Roelofs H
Stem Cells Transl Med; 2013 Jun; 2(6):455-63. PubMed ID: 23694810
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory properties of bone marrow mesenchymal stem cells.
Mohanty A; Polisetti N; Vemuganti GK
J Biosci; 2020; 45():. PubMed ID: 32713861
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
5. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp.
Pierdomenico L; Bonsi L; Calvitti M; Rondelli D; Arpinati M; Chirumbolo G; Becchetti E; Marchionni C; Alviano F; Fossati V; Staffolani N; Franchina M; Grossi A; Bagnara GP
Transplantation; 2005 Sep; 80(6):836-42. PubMed ID: 16210973
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells modulate allogeneic immune cell responses.
Aggarwal S; Pittenger MF
Blood; 2005 Feb; 105(4):1815-22. PubMed ID: 15494428
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro.
Wang M; Yang Y; Yang D; Luo F; Liang W; Guo S; Xu J
Immunology; 2009 Feb; 126(2):220-32. PubMed ID: 18624725
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory properties and therapeutic application of mesenchymal stem cells.
Shi M; Liu ZW; Wang FS
Clin Exp Immunol; 2011 Apr; 164(1):1-8. PubMed ID: 21352202
[TBL] [Abstract][Full Text] [Related]
9. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells.
Gieseke F; Böhringer J; Bussolari R; Dominici M; Handgretinger R; Müller I
Blood; 2010 Nov; 116(19):3770-9. PubMed ID: 20644118
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.
Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F
Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties.
Kimbrel EA; Kouris NA; Yavanian GJ; Chu J; Qin Y; Chan A; Singh RP; McCurdy D; Gordon L; Levinson RD; Lanza R
Stem Cells Dev; 2014 Jul; 23(14):1611-24. PubMed ID: 24650034
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of stem cells.
Wada N; Gronthos S; Bartold PM
Periodontol 2000; 2013 Oct; 63(1):198-216. PubMed ID: 23931061
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Yi T; Song SU
Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory and immunogenic properties of mesenchymal stem cells derived from bovine fetal bone marrow and adipose tissue.
Huaman O; Bahamonde J; Cahuascanco B; Jervis M; Palomino J; Torres CG; Peralta OA
Res Vet Sci; 2019 Jun; 124():212-222. PubMed ID: 30925336
[TBL] [Abstract][Full Text] [Related]
15. Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells.
Jacobs SA; Roobrouck VD; Verfaillie CM; Van Gool SW
Immunol Cell Biol; 2013 Jan; 91(1):32-9. PubMed ID: 23295415
[TBL] [Abstract][Full Text] [Related]
16. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.
Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F
J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344
[TBL] [Abstract][Full Text] [Related]
17. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.
Strioga M; Viswanathan S; Darinskas A; Slaby O; Michalek J
Stem Cells Dev; 2012 Sep; 21(14):2724-52. PubMed ID: 22468918
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.
Djouad F; Bouffi C; Ghannam S; Noël D; Jorgensen C
Nat Rev Rheumatol; 2009 Jul; 5(7):392-9. PubMed ID: 19568253
[TBL] [Abstract][Full Text] [Related]
19. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells.
Lee JM; Jung J; Lee HJ; Jeong SJ; Cho KJ; Hwang SG; Kim GJ
Int Immunopharmacol; 2012 Jun; 13(2):219-24. PubMed ID: 22487126
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory activity of mesenchymal stem cells.
Kaplan JM; Youd ME; Lodie TA
Curr Stem Cell Res Ther; 2011 Dec; 6(4):297-316. PubMed ID: 21190531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
